|Day Low/High||36.21 / 36.51|
|52 Wk Low/High||27.88 / 43.08|
The history we are concerned about is the past couple of weeks.
The vaccine rollout has been bungled and the nation's in crisis, but you can either dwell on the negativity or look to ingenuity and opportunity. Here's where I see the latter.
A potential breakthrough in Alzheimer's. A new device for blood pressure. More vaccines. These are opportunities to cheer in a time of turmoil.
I will have to give some of my favorite tech names a haircut in the name of balance. Hopefully everyone gained some exposure to gold.
As we move through Georgia and see an end in sight to Covid, we need a gut check on what stocks are really going to go the distance.
While there are certainly some things to like about AZN, I don't think this vaccine, nor the UK emergency authorization, make it investable.
I did something on Tuesday that I never thought that I would do again. I bought some Intel.
Also, electric vehicle maker Nio Inc. already has triggered an entry point.
Are traders working this holiday shortened week? You bet they are.
Let's look at the cold, hard facts around the vaccine rollout.
Plus, Coinbase files for an eventual initial public offering that should draw a ton of interest.
The stock hasn't done much of late, but perhaps FedEx's earnings report Thursday will offer clues of what's going on in delivery.
The Russell 2000 is now up 7% for December, twice the increase for the Nasdaq Composite.
We have bets coming from all directions, and holiday joy abounds as the wagerers move up their stocks with their buying. Let's see how this could play out.
I fear our legislators see these statistics and misunderstand the plight of the lower to middle class American in this environment.
Small caps stayed green while breadth lagged, and the S&P 500 has gone red for four days straight -- now, can we rally?
I am staying away from this name for now, despite the Alexion acquisition and vaccine promise.
Vaccines are on the move (a big plus) even as members of Congress continue to dawdle on a fiscal support package (a big minus).
Plus, stay nimble as the road just ahead could become a bit more treacherous than many may think.
If it doesn't end soon, the frenzy for select tech names could last until vaccines drive changes in consumer spending, or until inflation begins picking up.
The sooner that we get jabbed the more likely the economy can spring back to life.
There is little to no fear in the air, relative to what we as investors, and we as a people, have been through.
Most important come Inauguration Day is the seamless transition of leadership over 'Operation Warp Speed'.
The Divine Ms M and I Agree -- traders and investors should stop trying to make fetch happen.
Plus, what really is going to be the shape of this recovery?
Sure, stocks need to rest, but here's why I'm watching this ETF for the industrials. Also, let's look at the dollar and construction.
The level of new highs is a clear indication that market players are still working hard to put money to work and are willing to chase strength to do so.
The market appears to be trading off on news that Pfizer expects to ship half of the Covid-19 vaccines it originally planned for this year, because of supply-chain problems. But the pharma company still expects to roll out more than a billion doses ...
The great news about the pent-up demand rally? While these stocks have been creeping up they are now going to explode higher.
The RMPIA also tops other indexes for year, shooting ahead 29%.